Skip to main content
AAPL-0.08%MSFT-0.02%NVDA+0.30%GOOGL-4.07%AMZN+0.16%TSM-6.34%SPCX-1.26%META-0.24%AVGO-3.92%TSLA-0.26%LLY-0.82%BRK-B-0.02%WMT+0.25%JPM-2.31%SKHY-7.29%AMD-5.58%MU+0.38%V+0.16%XOM-2.12%JNJ-1.12%MA+0.08%ASMLa-2.51%ABBV-0.16%COST+0.68%1398.HK+2.15%0700.HK+0.98%KO+0.23%CVX-1.23%PG+1.96%CSCO-1.17%UNH+1.12%ORCL-5.03%0939.HK+1.71%3988.HK+1.59%HD-0.34%BAC-1.84%GE-2.00%1816.HK+2.57%0857.HK+0.58%1288.HK+1.60%0005.HK+0.43%PM-1.47%HSBA.L-0.37%NVS-0.19%INTC-7.07%MS-2.65%AZN-0.23%AP2d-0.61%AMAT-5.47%TXN-3.09%NOKJPY-1.08%USDNOK+0.91%CHFNOK+0.79%EURNOK+0.70%AUDJPY-0.67%NZDJPY-0.65%NZDMXN-0.55%AUDUSD-0.53%AUDSGD-0.52%NZDUSD-0.47%GBPTRY+0.41%NZDSGD-0.40%EURJPY-0.40%AUDCHF-0.40%GBPJPY-0.36%EURCNH-0.36%NZDCHF-0.36%AUDDKK-0.35%CADJPY-0.35%AUDNOK+0.35%USDZAR+0.34%PLNJPY-0.33%AUDCAD-0.33%GBPHKD+0.32%GBPAUD+0.30%EURAUD+0.30%NZDCAD-0.30%GBPMXN-0.28%CHFJPY-0.28%GBPNZD+0.28%USDSEK+0.26%EURNZD+0.24%SGDJPY-0.23%EURUSD-0.23%USDDKK+0.21%EURHKD-0.21%USDCAD+0.19%GBPUSD-0.19%GBPZAR+0.19%USDJPY-0.17%USDPLN+0.16%USDILS+0.16%GBPSGD-0.15%USDCHF+0.15%EURSGD-0.15%USDCNH-0.15%CHFSEK+0.13%EURZAR+0.12%USDMXN-0.10%EURCHF-0.07%CHFSGD-0.07%AUDNZD-0.05%USDTRY+0.05%USDSGD+0.05%CADCHF-0.05%EURPLN-0.05%EURCZK+0.04%EURSEK+0.04%GBPCHF-0.04%USDCOP-0.04%EURCAD-0.03%EURGBP-0.02%GBPCAD-0.01%USDHKD+0.01%USDTHB-0.01%EURDKK0.00%USOIL-4.62%UKOIL-4.61%XAGUSD-3.29%GAGUSD-3.29%XPTUSD-2.75%XNGUSD-2.71%HG1-1.03%GAUUSD-0.54%XAUUSD-0.54%COCOA0.00%S10.00%W10.00%BTCUSD-0.04%ETHUSD+56.78%USDTUSD-0.01%XRPUSD+54.01%SOLUSD+62.71%TRXUSDT+0.17%ZECUSDT-0.81%XMRUSDT-0.58%DOGEUSD+56.51%LINKUSD-1.29%XLMUSD-2.55%BCHUSDT-0.43%LTCUSD+46.82%UNIUSD-0.14%SUIUSD-1.74%TONUSD+59.79%HBARUSDT-2.73%TAOUSDT-1.55%AAVEUSD-1.41%ONDOUSDT-1.39%ICPUSDT+13.26%DOTUSDT-0.45%WLDUSDT-2.71%ARBUSDT-2.27%ATOMUSDT+2.55%INJUSDT-1.27%STXUSDT-2.35%PYTHUSDT-5.82%TIAUSDT-1.66%FETUSDT+0.36%SEIUSDT-0.49%JUPUSDT-7.90%OPUSDT-1.77%GRTUSDT-1.64%IOTAUSDT-0.04%POLUSDT-1.70%WIFUSDT+1.46%AXSUSDT-1.45%EOSUSDT+0.96%FARTCOINUSDT-3.22%IMXUSDT-2.11%GALAUSDT+0.50%DYDXUSDT+0.58%ORDIUSDT-0.90%NOTUSDT+0.53%RONINUSDT-2.38%AAPL-0.08%MSFT-0.02%NVDA+0.30%GOOGL-4.07%AMZN+0.16%TSM-6.34%SPCX-1.26%META-0.24%AVGO-3.92%TSLA-0.26%LLY-0.82%BRK-B-0.02%WMT+0.25%JPM-2.31%SKHY-7.29%AMD-5.58%MU+0.38%V+0.16%XOM-2.12%JNJ-1.12%MA+0.08%ASMLa-2.51%ABBV-0.16%COST+0.68%1398.HK+2.15%0700.HK+0.98%KO+0.23%CVX-1.23%PG+1.96%CSCO-1.17%UNH+1.12%ORCL-5.03%0939.HK+1.71%3988.HK+1.59%HD-0.34%BAC-1.84%GE-2.00%1816.HK+2.57%0857.HK+0.58%1288.HK+1.60%0005.HK+0.43%PM-1.47%HSBA.L-0.37%NVS-0.19%INTC-7.07%MS-2.65%AZN-0.23%AP2d-0.61%AMAT-5.47%TXN-3.09%NOKJPY-1.08%USDNOK+0.91%CHFNOK+0.79%EURNOK+0.70%AUDJPY-0.67%NZDJPY-0.65%NZDMXN-0.55%AUDUSD-0.53%AUDSGD-0.52%NZDUSD-0.47%GBPTRY+0.41%NZDSGD-0.40%EURJPY-0.40%AUDCHF-0.40%GBPJPY-0.36%EURCNH-0.36%NZDCHF-0.36%AUDDKK-0.35%CADJPY-0.35%AUDNOK+0.35%USDZAR+0.34%PLNJPY-0.33%AUDCAD-0.33%GBPHKD+0.32%GBPAUD+0.30%EURAUD+0.30%NZDCAD-0.30%GBPMXN-0.28%CHFJPY-0.28%GBPNZD+0.28%USDSEK+0.26%EURNZD+0.24%SGDJPY-0.23%EURUSD-0.23%USDDKK+0.21%EURHKD-0.21%USDCAD+0.19%GBPUSD-0.19%GBPZAR+0.19%USDJPY-0.17%USDPLN+0.16%USDILS+0.16%GBPSGD-0.15%USDCHF+0.15%EURSGD-0.15%USDCNH-0.15%CHFSEK+0.13%EURZAR+0.12%USDMXN-0.10%EURCHF-0.07%CHFSGD-0.07%AUDNZD-0.05%USDTRY+0.05%USDSGD+0.05%CADCHF-0.05%EURPLN-0.05%EURCZK+0.04%EURSEK+0.04%GBPCHF-0.04%USDCOP-0.04%EURCAD-0.03%EURGBP-0.02%GBPCAD-0.01%USDHKD+0.01%USDTHB-0.01%EURDKK0.00%USOIL-4.62%UKOIL-4.61%XAGUSD-3.29%GAGUSD-3.29%XPTUSD-2.75%XNGUSD-2.71%HG1-1.03%GAUUSD-0.54%XAUUSD-0.54%COCOA0.00%S10.00%W10.00%BTCUSD-0.04%ETHUSD+56.78%USDTUSD-0.01%XRPUSD+54.01%SOLUSD+62.71%TRXUSDT+0.17%ZECUSDT-0.81%XMRUSDT-0.58%DOGEUSD+56.51%LINKUSD-1.29%XLMUSD-2.55%BCHUSDT-0.43%LTCUSD+46.82%UNIUSD-0.14%SUIUSD-1.74%TONUSD+59.79%HBARUSDT-2.73%TAOUSDT-1.55%AAVEUSD-1.41%ONDOUSDT-1.39%ICPUSDT+13.26%DOTUSDT-0.45%WLDUSDT-2.71%ARBUSDT-2.27%ATOMUSDT+2.55%INJUSDT-1.27%STXUSDT-2.35%PYTHUSDT-5.82%TIAUSDT-1.66%FETUSDT+0.36%SEIUSDT-0.49%JUPUSDT-7.90%OPUSDT-1.77%GRTUSDT-1.64%IOTAUSDT-0.04%POLUSDT-1.70%WIFUSDT+1.46%AXSUSDT-1.45%EOSUSDT+0.96%FARTCOINUSDT-3.22%IMXUSDT-2.11%GALAUSDT+0.50%DYDXUSDT+0.58%ORDIUSDT-0.90%NOTUSDT+0.53%RONINUSDT-2.38%
DM

Disc Medicine, Inc. (IRON)

NASDAQ • Healthcare

$76.59
-$3.4 (-4.3%)
Market closed

Last close at November 16, 2026 at 21:00 UTC

Open$80.12
Day Range$76.4 - $80.37
Avg. Volume (3M)1.6M
Market Cap$2.9B
52 Week Range
$40$99.5

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$243.1M
EPS (TTM)
-$6.36
ROA (TTM)
-34.75%
Current Ratio
20.3

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-6.5%Q2 2026-$1.65
+9.9%Q3 2026-$1.54
+6.1%Q4 2026-$1.53

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +6.1%

Disc Medicine’s preliminary results for the third fiscal quarter of 2026 topped consensus on EPS, with -$1.53 coming in ahead of the -$1.63 estimate by $0.10, based on results reported November 5, 2026. The quarter’s GAAP net loss narrowed to roughly -$59.5 million, a +5% year-over-year improvement from about -$62.3 million, while EPS improved +14% from -$1.77 a year ago. Profitability remained negative, with operating income around -$64.2 million, and cash generation was also negative as operating cash flow was roughly -$40.2 million. For the next period, consensus calls for EPS of -$1.67 on revenue of $3.7 million.

View full earnings history

About Disc Medicine, Inc.

Disc Medicine, Inc. is a NASDAQ-listed Biotechnology company in the healthcare sector focused on therapies for red blood cell biology. Trading under the ticker IRON, it works on diseases tied to heme biosynthesis and iron homeostasis. In qualitative terms, Disc Medicine is a clinical-stage biotech.

Name
Disc Medicine, Inc.
CEO
John D. Quisel
Industry
Healthcare
Employees
165

Today's Snapshot

AI-generated

The day ended with IRON 4.3% lower at 76.59, while its sector was flat.

Trading Volume

Below 10d avg (1.0M)

784.6K

vs S&P 500 Today

Underperforming Market

-2.36%

Updated: November 16, 2026 at 21:26 UTC

Technical Indicators

3 Buy3 Neutral2 Sell
IRON shows a mixed but net constructive technical setup, with ADX indicating a reasonably strong trend while price sits below short-term averages but above most longer-term moving averages, suggesting medium-term support. Momentum readings are mixed—near-term momentum is negative but MACD is not bearish and Williams %R is signaling oversold conditions—while ATR reflects elevated volatility. On-balance volume appears supportive despite a negative nominal reading, and the classic pivot is above current price. Technical takeaway: trend and longer-term moving-average support favor a buy posture amid short-term weakness.
All signals
  • EMA (5 indicators)$73.42 - $80.62
    Buy
  • RSI (14)49.12
    Neutral
  • Stochastic %K (14, 3, 3)33.28
    Neutral
  • MACD Level (12, 26)2.95
    Neutral

Peers & Related Assets

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.